Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Assets Average: 2022-2025

Historic Assets Average for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $8.1 million.

  • bioAffinity Technologies' Assets Average rose 23.39% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 23.39%. This contributed to the annual value of $7.4 million for FY2024, which is 27.78% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Assets Average stood at $8.1 million, which was up 58.25% from $5.1 million recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Assets Average peaked at $13.1 million during Q4 2022, and registered a low of $5.1 million during Q2 2025.
  • In the last 3 years, bioAffinity Technologies' Assets Average had a median value of $8.1 million in 2024 and averaged $8.0 million.
  • Its Assets Average has fluctuated over the past 5 years, first plummeted by 30.71% in 2024, then grew by 23.39% in 2025.
  • Over the past 4 years, bioAffinity Technologies' Assets Average (Quarterly) stood at $13.1 million in 2022, then fell by 29.85% to $9.2 million in 2023, then dropped by 29.03% to $6.5 million in 2024, then increased by 23.39% to $8.1 million in 2025.
  • Its Assets Average was $8.1 million in Q3 2025, compared to $5.1 million in Q2 2025 and $6.0 million in Q1 2025.